Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Pan S, Tsakok T, Dand N, Lonsdale DO, Loeff FC, Bloem K, de Vries A, Baudry D, Duckworth M, Mahil S, Pushpa-Rajah A, Russell A, Alsharqi A, Becher G, Murphy R, Wahie S, Wright A, Griffiths CEM, Reynolds NJ, Barker J, Warren RB, David Burden A, Rispens T, Standing JF, Smith CH; BADBIR Study Group, the BSTOP Study Group, the PSORT Consortium.

Clin Transl Sci. 2020 Jan 29. doi: 10.1111/cts.12725. [Epub ahead of print]

PMID:
31995663
2.

Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis.

Tsakok T, Wilson N, Dand N, Loeff FC, Bloem K, Baudry D, Duckworth M, Pan S, Pushpa-Rajah A, Standing JF, de Vries A, Alsharqi A, Becher G, Murphy R, Wahie S, Wright A, Griffiths CEM, Reynolds NJ, Barker J, Warren RB, Burden AD, Rispens T, Stocken D, Smith C; British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR) Study Group and the Psoriasis Stratification to Optimise Relevant Therapy (PSORT) Consortium.

JAMA Dermatol. 2019 Sep 18. doi: 10.1001/jamadermatol.2019.1783. [Epub ahead of print]

3.

Concentrations of selected chemicals in indoor air from Norwegian homes and schools.

Sakhi AK, Cequier E, Becher R, Bølling AK, Borgen AR, Schlabach M, Schmidbauer N, Becher G, Schwarze P, Thomsen C.

Sci Total Environ. 2019 Jul 15;674:1-8. doi: 10.1016/j.scitotenv.2019.04.086. Epub 2019 Apr 9.

4.

[The Role of Air Pollutants for Health - A Reply to the Expert Opinion of the International Society for Environmental Epidemiology (ISEE) and the European Respiratory Society (ERS)].

Köhler D, Hetzel M, Klingner M, Koch T, Ewig S, Becher G, Lindemann H, Voshaar T, Costabel U.

Pneumologie. 2019 May;73(5):274-287. doi: 10.1055/a-0873-3574. Epub 2019 Apr 16. German.

PMID:
30991436
5.

Recent progress of chemistry as scientific tool for environmental assessments-ICCE 2017 : The 16th EuCheMS International Conference on Chemistry and the Environment-ICCE 2017 Oslo, 18-22 June 2017.

Kallenborn R, Becher G, Thomassen Y.

Environ Sci Pollut Res Int. 2019 Mar;26(8):7301-7304. doi: 10.1007/s11356-019-04298-9. Epub 2019 Feb 19. No abstract available.

PMID:
30778949
6.

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis.

Dand N, Duckworth M, Baudry D, Russell A, Curtis CJ, Lee SH, Evans I, Mason KJ, Alsharqi A, Becher G, Burden AD, Goodwin RG, McKenna K, Murphy R, Perera GK, Rotarescu R, Wahie S, Wright A, Reynolds NJ, Warren RB, Griffiths CEM, Smith CH, Simpson MA, Barker JN; BADBIR Study Group; BSTOP Study Group; PSORT Consortium.

J Allergy Clin Immunol. 2019 Jun;143(6):2120-2130. doi: 10.1016/j.jaci.2018.11.038. Epub 2018 Dec 20.

PMID:
30578879
7.

Ixekizumab in genital psoriasis.

Becher G, Burden AD.

Br J Dermatol. 2018 Oct;179(4):811-812. doi: 10.1111/bjd.17038. No abstract available.

PMID:
30318814
8.

Monitoring of omalizumab therapy in children and adolescents.

Steiß JO, Schmidt A, Lindemann H, Rudloff S, Staatz A, Strohner P, Becher G, Nährlich L, Zimmer KP.

Allergol Select. 2018 Sep 1;2(1):32-38. doi: 10.5414/ALX01337E. eCollection 2018.

9.

Improved adalimumab dose decision with comprehensive diagnostics data.

Zänker M, Becher G, Arbach O, Maurer M, Stuhlmüller B, Schäfer A, Strohner P, Brand J.

Clin Exp Rheumatol. 2018 Jan-Feb;36(1):136-139. Epub 2017 Aug 28.

PMID:
28850025
10.

Serum levels of decabromodiphenyl ether (BDE-209) in women from different European countries and possible relationships with lifestyle and diet.

van den Berg M, Houba R, Leslie HA, Canton RF, Thomsen C, Becher G, Alvarez-Pedrerol M, Deu JS, Steiner M, van Tongeren M, Brunekreef B, de Boer J.

Environ Int. 2017 Oct;107:16-24. doi: 10.1016/j.envint.2017.06.014. Epub 2017 Jun 23.

PMID:
28651164
11.

Detection of mycobacteria by volatile organic compound analysis of invitro cultures using differential ion mobility spectrometry.

Purkhart R, Becher G, Reinhold P, Köhler HU.

J Med Microbiol. 2017 Mar;66(3):276-285. doi: 10.1099/jmm.0.000410. Epub 2017 Mar 23.

PMID:
27995864
12.

Necrotizing eosinophilic folliculitis: a new manifestation of the atopic diathesis?

Cunningham F, Gupta P, Becher G, Magro CM.

Clin Exp Dermatol. 2017 Jan;42(1):100-101. doi: 10.1111/ced.12994. Epub 2016 Dec 2. No abstract available.

PMID:
27910130
13.

The Path Forward on Endocrine Disruptors Requires Focus on the Basics.

Zoeller RT, Bergman Å, Becher G, Bjerregaard P, Bornman R, Brandt I, Iguchi T, Jobling S, Kidd KA, Kortenkamp A, Skakkebaek N, Toppari J, Vandenberg L.

Toxicol Sci. 2016 Feb;149(2):272. doi: 10.1093/toxsci/kfv329. No abstract available.

PMID:
26811417
14.

Brominated flame retardants - Exposure and risk assessment for the general population.

Fromme H, Becher G, Hilger B, Völkel W.

Int J Hyg Environ Health. 2016 Jan;219(1):1-23. doi: 10.1016/j.ijheh.2015.08.004. Epub 2015 Sep 8. Review.

PMID:
26412400
15.

Manufacturing doubt about endocrine disrupter science--A rebuttal of industry-sponsored critical comments on the UNEP/WHO report "State of the Science of Endocrine Disrupting Chemicals 2012".

Bergman Å, Becher G, Blumberg B, Bjerregaard P, Bornman R, Brandt I, Casey SC, Frouin H, Giudice LC, Heindel JJ, Iguchi T, Jobling S, Kidd KA, Kortenkamp A, Lind PM, Muir D, Ochieng R, Ropstad E, Ross PS, Skakkebaek NE, Toppari J, Vandenberg LN, Woodruff TJ, Zoeller RT.

Regul Toxicol Pharmacol. 2015 Dec;73(3):1007-17. doi: 10.1016/j.yrtph.2015.07.026. Epub 2015 Jul 31.

16.

Assessment of human hair as an indicator of exposure to organophosphate flame retardants. Case study on a Norwegian mother-child cohort.

Kucharska A, Cequier E, Thomsen C, Becher G, Covaci A, Voorspoels S.

Environ Int. 2015 Oct;83:50-7. doi: 10.1016/j.envint.2015.05.015. Epub 2015 Jun 14.

PMID:
26081984
17.

A path forward in the debate over health impacts of endocrine disrupting chemicals.

Zoeller RT, Bergman Å, Becher G, Bjerregaard P, Bornman R, Brandt I, Iguchi T, Jobling S, Kidd KA, Kortenkamp A, Skakkebaek NE, Toppari J, Vandenberg LN.

Environ Health. 2014 Dec 22;13:118. doi: 10.1186/1476-069X-13-118.

18.

Policy recommendations and cost implications for a more sustainable framework for European human biomonitoring surveys.

Joas A, Knudsen LE, Kolossa-Gehring M, Sepai O, Casteleyn L, Schoeters G, Angerer J, Castaño A, Aerts D, Biot P, Horvat M, Bloemen L, Reis MF, Lupsa IR, Katsonouri A, Cerna M, Berglund M, Crettaz P, Rudnai P, Halzlova K, Mulcahy M, Gutleb AC, Fischer ME, Becher G, Fréry N, Jensen G, Van Vliet L, Koch HM, Den Hond E, Fiddicke U, Esteban M, Exley K, Schwedler G, Seiwert M, Ligocka D, Hohenblum P, Kyrtopoulos S, Botsivali M, DeFelip E, Guillou C, Reniero F, Grazuleviciene R, Veidebaum T, Mørck TA, Nielsen JK, Jensen JF, Rivas TC, Sanchez J, Koppen G, Smolders R, Kozepesy S, Hadjipanayis A, Krskova A, Mannion R, Jakubowski M, Fucic JA, Pereira-Miguel J, Gurzau AE, Jajcaj M, Mazej D, Tratnik JS, Lehmann A, Larsson K, Dumez B, Joas R.

Environ Res. 2015 Aug;141:42-57. doi: 10.1016/j.envres.2014.10.012. Epub 2014 Dec 17.

PMID:
25526891
19.

Human exposure pathways to organophosphate triesters - a biomonitoring study of mother-child pairs.

Cequier E, Sakhi AK, Marcé RM, Becher G, Thomsen C.

Environ Int. 2015 Feb;75:159-65. doi: 10.1016/j.envint.2014.11.009. Epub 2014 Nov 26.

20.

Comparing human exposure to emerging and legacy flame retardants from the indoor environment and diet with concentrations measured in serum.

Cequier E, Marcé RM, Becher G, Thomsen C.

Environ Int. 2015 Jan;74:54-9. doi: 10.1016/j.envint.2014.10.003. Epub 2014 Oct 17.

PMID:
25454220
21.

A high-throughput method for determination of metabolites of organophosphate flame retardants in urine by ultra performance liquid chromatography-high resolution mass spectrometry.

Cequier E, Marcé RM, Becher G, Thomsen C.

Anal Chim Acta. 2014 Oct 3;845:98-104. doi: 10.1016/j.aca.2014.06.026. Epub 2014 Jun 17.

PMID:
25201278
22.

Re: Baker DL et al. Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy. Curr Med Res Opin 2014;30:913-22.

Strohner P, Becher G.

Curr Med Res Opin. 2014 Oct;30(10):1923-5. doi: 10.1185/03007995.2014.933099. Epub 2014 Jul 7. No abstract available.

PMID:
24914579
23.

Optimisation of omalizumab dosage in patients with severe persistent allergic asthma using recoveryELISA.

Steiß JO, Becher G.

BioDrugs. 2014 Oct;28(5):445-50. doi: 10.1007/s40259-014-0101-6.

PMID:
24898594
24.

Occurrence of a broad range of legacy and emerging flame retardants in indoor environments in Norway.

Cequier E, Ionas AC, Covaci A, Marcé RM, Becher G, Thomsen C.

Environ Sci Technol. 2014 Jun 17;48(12):6827-35. doi: 10.1021/es500516u. Epub 2014 May 23.

PMID:
24846325
25.

Palmoplantar pustulosis--a retrospective review of comorbid conditions.

Becher G, Jamieson L, Leman J.

J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1854-6. doi: 10.1111/jdv.12545. Epub 2014 May 12. No abstract available.

PMID:
24813766
26.

Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.

Starling AP, Engel SM, Richardson DB, Baird DD, Haug LS, Stuebe AM, Klungsøyr K, Harmon Q, Becher G, Thomsen C, Sabaredzovic A, Eggesbø M, Hoppin JA, Travlos GS, Wilson RE, Trogstad LI, Magnus P, Longnecker MP.

Am J Epidemiol. 2014 Apr 1;179(7):824-33. doi: 10.1093/aje/kwt432. Epub 2014 Feb 20.

27.

Exposure to polybrominated diphenyl ethers and male reproductive function in Greenland, Poland and Ukraine.

Toft G, Lenters V, Vermeulen R, Heederik D, Thomsen C, Becher G, Giwercman A, Bizzaro D, Manicardi GC, Spanò M, Rylander L, Pedersen HS, Struciński P, Zviezdai V, Bonde JP.

Reprod Toxicol. 2014 Jan;43:1-7.

PMID:
24513925
28.

Treatment of superficial vascular lesions with the KTP 532-nm laser: experience with 647 patients.

Becher GL, Cameron H, Moseley H.

Lasers Med Sci. 2014 Jan;29(1):267-71. doi: 10.1007/s10103-013-1330-5. Epub 2013 Apr 30.

PMID:
24401943
29.

Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.

Starling AP, Engel SM, Whitworth KW, Richardson DB, Stuebe AM, Daniels JL, Haug LS, Eggesbø M, Becher G, Sabaredzovic A, Thomsen C, Wilson RE, Travlos GS, Hoppin JA, Baird DD, Longnecker MP.

Environ Int. 2014 Jan;62:104-12. doi: 10.1016/j.envint.2013.10.004. Epub 2013 Nov 2.

30.

Long-term effects of prenatal exposure to perfluoroalkyl substances on female reproduction.

Kristensen SL, Ramlau-Hansen CH, Ernst E, Olsen SF, Bonde JP, Vested A, Halldorsson TI, Becher G, Haug LS, Toft G.

Hum Reprod. 2013 Dec;28(12):3337-48. doi: 10.1093/humrep/det382. Epub 2013 Oct 15.

PMID:
24129614
31.

Serum concentrations of polybrominated diphenyl ethers (PBDEs) and a polybrominated biphenyl (PBB) in men from Greenland, Poland and Ukraine.

Lenters V, Thomsen C, Smit LA, Jönsson BA, Pedersen HS, Ludwicki JK, Zviezdai V, Piersma AH, Toft G, Bonde JP, Becher G, Vermeulen R, Heederik D.

Environ Int. 2013 Nov;61:8-16. doi: 10.1016/j.envint.2013.09.001. Epub 2013 Oct 2.

PMID:
24091254
32.

Association between perfluoroalkyl substances and thyroid stimulating hormone among pregnant women: a cross-sectional study.

Wang Y, Starling AP, Haug LS, Eggesbo M, Becher G, Thomsen C, Travlos G, King D, Hoppin JA, Rogan WJ, Longnecker MP.

Environ Health. 2013 Sep 8;12(1):76. doi: 10.1186/1476-069X-12-76.

33.

Determination of emerging halogenated flame retardants and polybrominated diphenyl ethers in serum by gas chromatography mass spectrometry.

Cequier E, Marcé RM, Becher G, Thomsen C.

J Chromatogr A. 2013 Oct 4;1310:126-32. doi: 10.1016/j.chroma.2013.08.067. Epub 2013 Aug 21.

PMID:
23992842
34.

Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editors.

Bergman Å, Andersson AM, Becher G, van den Berg M, Blumberg B, Bjerregaard P, Bornehag CG, Bornman R, Brandt I, Brian JV, Casey SC, Fowler PA, Frouin H, Giudice LC, Iguchi T, Hass U, Jobling S, Juul A, Kidd KA, Kortenkamp A, Lind M, Martin OV, Muir D, Ochieng R, Olea N, Norrgren L, Ropstad E, Ross PS, Rudén C, Scheringer M, Skakkebaek NE, Söder O, Sonnenschein C, Soto A, Swan S, Toppari J, Tyler CR, Vandenberg LN, Vinggaard AM, Wiberg K, Zoeller RT.

Environ Health. 2013 Aug 27;12:69. doi: 10.1186/1476-069X-12-69.

35.

[Omalizumab therapy in adolescents with severe allergic asthma - observational study ].

Steiß JO, Lindemann H, Becher G.

Pneumologie. 2013 Jun;67(6):355. doi: 10.1055/s-0033-1344176. Epub 2013 Jun 7. German. No abstract available.

36.

The impact of endocrine disruption: a consensus statement on the state of the science.

Bergman A, Heindel JJ, Kasten T, Kidd KA, Jobling S, Neira M, Zoeller RT, Becher G, Bjerregaard P, Bornman R, Brandt I, Kortenkamp A, Muir D, Drisse MN, Ochieng R, Skakkebaek NE, Byléhn AS, Iguchi T, Toppari J, Woodruff TJ.

Environ Health Perspect. 2013 Apr;121(4):A104-6. doi: 10.1289/ehp.1205448. No abstract available.

37.

Cutaneous scleroderma and malignant carcinoid syndrome.

Becher G, Leman J.

Clin Exp Dermatol. 2013 Apr;38(3):310-1. doi: 10.1111/ced.12046. No abstract available.

PMID:
23517363
38.

Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.

Brantsæter AL, Whitworth KW, Ydersbond TA, Haug LS, Haugen M, Knutsen HK, Thomsen C, Meltzer HM, Becher G, Sabaredzovic A, Hoppin JA, Eggesbø M, Longnecker MP.

Environ Int. 2013 Apr;54:74-84. doi: 10.1016/j.envint.2012.12.014. Epub 2013 Feb 15.

39.

Associations of in utero exposure to perfluorinated alkyl acids with human semen quality and reproductive hormones in adult men.

Vested A, Ramlau-Hansen CH, Olsen SF, Bonde JP, Kristensen SL, Halldorsson TI, Becher G, Haug LS, Ernst EH, Toft G.

Environ Health Perspect. 2013 Apr;121(4):453-8. doi: 10.1289/ehp.1205118. Epub 2013 Jan 28.

40.

The recovery-ELISA--a novel assay technique to monitor therapy with humanized antibodies: the example of omalizumab.

Strohner P, Korn S, Buhl R, Becher G.

J Immunoassay Immunochem. 2013;34(1):83-93. doi: 10.1080/15321819.2012.683501.

PMID:
23323984
41.

Erythema multiforme and Malarone(®).

Becher G, Wylie G.

Travel Med Infect Dis. 2012 Sep;10(5-6):279-80. doi: 10.1016/j.tmaid.2012.08.002. Epub 2012 Aug 28. No abstract available.

PMID:
22951669
42.

Monitoring free serum IgE in severe asthma patients treated with omalizumab.

Korn S, Haasler I, Fliedner F, Becher G, Strohner P, Staatz A, Taube C, Buhl R.

Respir Med. 2012 Nov;106(11):1494-500. doi: 10.1016/j.rmed.2012.07.010. Epub 2012 Aug 11.

43.

Persistent organic pollutants (POPs) in human milk: a biomonitoring study in rural areas of Flanders (Belgium).

Croes K, Colles A, Koppen G, Govarts E, Bruckers L, Van de Mieroop E, Nelen V, Covaci A, Dirtu AC, Thomsen C, Haug LS, Becher G, Mampaey M, Schoeters G, Van Larebeke N, Baeyens W.

Chemosphere. 2012 Nov;89(8):988-94. doi: 10.1016/j.chemosphere.2012.06.058. Epub 2012 Jul 26.

PMID:
22840535
44.

Understanding the variation in response to methotrexate.

Becher G, Burden AD.

Br J Dermatol. 2012 Jul;167(1):2-3. doi: 10.1111/j.1365-2133.2012.11028.x. No abstract available.

PMID:
22738410
45.

Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort Study.

Whitworth KW, Haug LS, Baird DD, Becher G, Hoppin JA, Skjaerven R, Thomsen C, Eggesbo M, Travlos G, Wilson R, Cupul-Uicab LA, Brantsaeter AL, Longnecker MP.

Am J Epidemiol. 2012 Jun 15;175(12):1209-16. doi: 10.1093/aje/kwr459. Epub 2012 Apr 19.

46.

Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study.

Halldorsson TI, Rytter D, Haug LS, Bech BH, Danielsen I, Becher G, Henriksen TB, Olsen SF.

Environ Health Perspect. 2012 May;120(5):668-73. doi: 10.1289/ehp.1104034. Epub 2012 Feb 3.

47.

Perfluorinated compounds and subfecundity in pregnant women.

Whitworth KW, Haug LS, Baird DD, Becher G, Hoppin JA, Skjaerven R, Thomsen C, Eggesbo M, Travlos G, Wilson R, Longnecker MP.

Epidemiology. 2012 Mar;23(2):257-63. doi: 10.1097/EDE.0b013e31823b5031.

48.

Placental transfer of perfluorinated compounds is selective--a Norwegian Mother and Child sub-cohort study.

Gützkow KB, Haug LS, Thomsen C, Sabaredzovic A, Becher G, Brunborg G.

Int J Hyg Environ Health. 2012 Feb;215(2):216-9. doi: 10.1016/j.ijheh.2011.08.011. Epub 2011 Sep 19.

PMID:
21937271
49.

Action spectrum for etofenamate photoallergic contact dermatitis.

Kerr A, Becher G, Ibbotson S, Ferguson J.

Contact Dermatitis. 2011 Aug;65(2):117-8. doi: 10.1111/j.1600-0536.2011.01920.x. No abstract available.

PMID:
21745218
50.

Associations between brominated flame retardants in human milk and thyroid-stimulating hormone (TSH) in neonates.

Eggesbø M, Thomsen C, Jørgensen JV, Becher G, Odland JØ, Longnecker MP.

Environ Res. 2011 Aug;111(6):737-43. doi: 10.1016/j.envres.2011.05.004. Epub 2011 May 20.

Supplemental Content

Loading ...
Support Center